(Q33739880)

29 July 2017

1 reference

title

Atrial fibrillation and anabolic steroids (English)

1 reference

29 July 2017

1 reference

Sullivan ML

1

1 reference

29 July 2017

Martinez CM

series ordinal

2

1 reference

29 July 2017

Gallagher EJ

series ordinal

3

1 reference

29 July 2017

language of work or name

1 reference

1 September 1999

1 reference

Journal of Emergency Medicine

29 July 2017

published in

1 reference

29 July 2017

volume

17

1 reference

29 July 2017

issue

5

1 reference

29 July 2017

page(s)

851-857

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900095-5

29 July 2017

1 reference

7 January 2021

Illicit anabolic steroid use in athletes. A case series analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900095-5

7 January 2021

Misusing anabolic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900095-5

7 January 2021

Anabolic steroids in the athlete

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900095-5

7 January 2021

Cardiovascular toxicity of anabolic steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900095-5

7 January 2021

Myocardial infarction associated with anabolic steroid use in a previously healthy 37-year-old weight lifter

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900095-5

7 January 2021

Acute myocardial infarction in a 22-year-old world class weight lifter using anabolic steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900095-5

7 January 2021

Myocardial infarction, hyperkalaemia and ventricular tachycardia in a young male body-builder

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900095-5

7 January 2021

Bioenergetics in the pathogenesis, progression and treatment of cardiovascular disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900095-5

7 January 2021

Left ventricular size and function in body builders using anabolic steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900095-5

7 January 2021

Epidemiologic features of chronic atrial fibrillation: the Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900095-5

7 January 2021

Why does atrial fibrillation occur?

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900095-5

7 January 2021

The natural history of lone atrial fibrillation. A population-based study over three decades

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900095-5

7 January 2021

Atrial flutter, atrial fibrillation, and other primary atrial tachycardias.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900095-5

7 January 2021

Sudden death in young athletes

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900095-5

7 January 2021

The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900095-5

7 January 2021

The preexcitation syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900095-5

7 January 2021

Tachycardia-bradycardia syndrome (so-called "sick sinus syndrome"). Pathology, mechanisms and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900095-5

7 January 2021

Occult thyrotoxicosis: A correctable cause of “idiopathic” atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900095-5

7 January 2021

Androgenic-anabolic steroid effects on serum thyroid, pituitary and steroid hormones in athletes

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900095-5

7 January 2021

Alteration of hormone levels in normal males given the anabolic steroid stanozolol

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900095-5

7 January 2021

Cardiovascular complications and anabolic steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900095-5

7 January 2021

Anabolic steroid use as the possible precipitant of dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900095-5

7 January 2021

Sudden cardiac death in a 20-year-old bodybuilder using anabolic steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900095-5

7 January 2021

Myocardial infarction and cerebral haemorrhage in a young body builder taking anabolic steroids.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900095-5

7 January 2021

Increased left ventricular mass in a bodybuilder using anabolic steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900095-5

7 January 2021

Cardiomyopathy and Cerebrovascular Accident Associated With Anabolic-Androgenic Steroid Use

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900095-5

7 January 2021

One- and two-dimensional echocardiography in bodybuilders using anabolic steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900095-5

7 January 2021

Anabolic steroid use in body builders: an echocardiographic study of left ventricle morphology and function

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900095-5

7 January 2021

Binding and metabolism of testosterone and of 5-dihydrotestosterone in bulbocavernous/levator ani (BCLA) of male rats: in vivo and in vitro studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900095-5

7 January 2021

Anabolic steroids: a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900095-5

7 January 2021

Use of androgenic anabolic steroids by athletes

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900095-5

7 January 2021

Androgen abuse by athletes

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900095-5

7 January 2021

10.1016/S0736-4679(99)00095-5

Identifiers

DOI

1 reference

29 July 2017

1 reference